Drugs Worth Rs 4.87L Of ESI Hospital Supply Found In A Raid

Hyderabad:  The Telangana Drugs Control Administration (DCA), Karimnagar Zone, raided Srinivasa Medical and General Stores, located in Osmanpura, Karimnagar, and discovered drugs supplied for ESI hospital illegally stocked for sale.

During the raid, five types of drugs labelled ‘ESI SUPPLY NOT FOR SALE’ were seized, with the stock valued at Rs 4.87 lakh. The seized medications included antidiabetic and antiasthmatic drugs, among others.

DG DCA, V Kamalasan Reddy, reported that Dunaboina Murali Rao, a pharmacist grade-II at the ESI dispensary in SPM Colony, Sirpur-Kagaznagar, Kumuram Bheem Asifabad district, had illegally diverted ESI hospital supplies to managing partner of Sri Srinivasa Medical and General Stores, Gampa Krishna, in Karimnagar.

The raid was conducted by the assistant director, Karimnagar, M Srinivasulu, alongside drugs inspectors P Karthik Bharadwaj, T Chandana and P Shravan Kumar, from Karimnagar, Mancherial and Peddapalli.

DCA officers have taken samples for analysis, and further investigation is underway. Legal action will be taken against all offenders in accordance with the law.

Government pharmacists found guilty of illegally diverting hospital supplies are punishable under the Drugs and Cosmetics Act (DCA), with stringent measures promised against such individuals.

Officials warned that the illegal stocking of ESI hospital supply drugs for sale is punishable under the Drugs and Cosmetics Act, with imprisonment of up to two years.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit